BioPharma Clinical Trials
Doer Biologics Begins Phase 2 Study of First-in-Class Tri-Agonist DR10624 for Severe Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...
October 01, 2024 | News
Anbogen Partners with BeiGene to Launch Global Phase II Trial for Innovative Colorectal Cancer Treatment
Anbogen, a clinical-stage biotech company, announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301, with Bei...
September 30, 2024 | News
BioCity Biopharma's SC0062 Receives Breakthrough Therapy Designation from NMPA for Treatment of IgA Nephropathy
BioCity Biopharma (BioCity) announced its endothelin receptor type A (ETA) selective antagonist SC0062 has been granted the Breakthrough Therapy Desig...
September 27, 2024 | News
Minovia Therapeutics Receives FDA Clearance to Initiate Phase Ib Trial for Mitochondrial Cell Therapy in Low-Risk MDS Patients
MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clini...
September 27, 2024 | News
Kangpu Biopharmaceuticals Successfully Completes Bridging Clinical Study of KPG-818 in Healthy Subjects in China
Kangpu Biopharmaceuticals, a clinical-stage company based in Hefei, China, announced that the Company has successfully completed a bridging clinical s...
September 23, 2024 | News
Henlius Receives Positive CHMP Opinion for HANSIZHUANG (Serplulimab) as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer in Europe
Shanghai Henlius Biotech, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued ...
September 23, 2024 | News
Hyundai Bioscience Partners with UC San Diego for Pioneering Long-COVID Clinical Trial of Antiviral Xafty®
Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an invest...
September 18, 2024 | News
Massive Bio Launches Free AI-Powered Portal to Simplify Cancer Clinical Trial Enrollment for Patients Worldwide
Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovati...
September 17, 2024 | News
Aurora Biosynthetics Launches to Transform RNA Therapeutics Manufacturing in Asia-Pacific
Aurora Biosynthetics, a pioneering advanced RNA therapeutics manufacturing company, announced its official launch. This heralds a new era in RNA therapeuti...
September 13, 2024 | News
HighTide Therapeutics Presents Promising Data on HTD1801 for Type 2 Diabetes at EASD 2024
HighTide Therapeutics, Inc. (2511.HK), a clinical-stage biopharmaceutical company dedicated to developing multifunctional therapies for chronic liver and m...
September 12, 2024 | News
Avistone Biotechnology Presents Promising Clinical Results of Dual c-MET and EGFR Inhibitors for NSCLC at WCLC 2024
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision...
September 11, 2024 | News
Ractigen Therapeutics Reports Positive Clinical Data from ALS-SOD1 Trial of RAG-17
Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing innovative therapies, announced promising clinical data from an Inve...
September 11, 2024 | News
Nuance Pharma Completes Patient Recruitment for Pivotal ENHANCE-CHINA COPD Study
Nuance Pharma announced it has completed the recruitment of patients for the ENHANCE-CHINA (NCT05743075) study, after planned number of patients have ...
September 11, 2024 | News
GenAssist Doses First DMD Patient with Pioneering Base Editing Drug GEN6050X in Clinical Trial
GenAssist Ltd (GenAssist), announced the first DMD patient dosed with its base editing drug, GEN6050X injection, in an investigator-initiated trial (IIT). ...
September 10, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
